Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort study
Abstract Background Mesentericoportal vein (MPV) resection in pancreatic ductal adenocarcinoma (PDAC) surgery has become a common procedure. A few studies had described the use of falciform ligament (FL) for MPV reconstruction and received encouraging preliminary effects. Aims This study was designe...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | BMC Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12893-020-01019-9 |
id |
doaj-4bda5857023c4de9a29c42d3c60673ab |
---|---|
record_format |
Article |
spelling |
doaj-4bda5857023c4de9a29c42d3c60673ab2021-01-10T12:33:30ZengBMCBMC Surgery1471-24822021-01-012111810.1186/s12893-020-01019-9Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort studyYi Shao0Jiaojiao Feng1Yuancong Jiang2Zhenhua Hu3Jian Wu4Min Zhang5Yan Shen6Shusen Zheng7Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityDepartment of Gynecologic Oncology, Women’s Hospital, School of Medicine, Zhejiang UniversityDepartment of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityDepartment of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityDepartment of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityDepartment of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityDepartment of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityDepartment of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityAbstract Background Mesentericoportal vein (MPV) resection in pancreatic ductal adenocarcinoma (PDAC) surgery has become a common procedure. A few studies had described the use of falciform ligament (FL) for MPV reconstruction and received encouraging preliminary effects. Aims This study was designed to explore the feasibility and efficacy of this technique compared with others. Methods Patients who underwent pancreaticoduodenectomy (PD) with MPV resection for PDAC from 2009 to 2018 were enrolled. Medical records were retrospectively reviewed, MPV reconstructions using FL were distinguished and compared with other techniques. Results 146 patients underwent MPV reconstruction, and 13 received FL venoplasty. Other reconstruction techniques included primary end-to-end anastomosis (primary, n = 30), lateral venorrhaphy (LV, n = 19), polytetrafluoroethylene conduit interposition (PTFE, n = 24), iliac artery (IA) allografts interposition (n = 47), and portal vein (PV) allografts interposition (n = 13). FL group holds the advantages of shortest operation time (p = 0.023), lowest blood loss (p = 0.109), and shortest postoperative hospital stay (p = 0.125). The grouped patency rates of FL, primary, LV, PTFE, IA, and PV were 100%, 90%, 68%, 54%, 68%, and 85% respectively. Comparison displayed that FL had the highest patency rate (p = 0.008) and lowest antiplatelet/anticoagulation proportion (p = 0.000). Complications and long-term survival were similar among different techniques. The median survival time of patent group (24.0 months, 95% CI: 22.0–26.0) was much longer than that of the thrombosed (17.0 months, 95% CI: 13.7–20.3), though without significant difference (P = 0.148). Conclusions PD with MPV resection and reconstruction by FL is safe, feasible, and efficacious, it might provide a potential benefit for patients.https://doi.org/10.1186/s12893-020-01019-9Pancreatic cancerVenous reconstruction techniqueFalciform ligamentPatencySurvival |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yi Shao Jiaojiao Feng Yuancong Jiang Zhenhua Hu Jian Wu Min Zhang Yan Shen Shusen Zheng |
spellingShingle |
Yi Shao Jiaojiao Feng Yuancong Jiang Zhenhua Hu Jian Wu Min Zhang Yan Shen Shusen Zheng Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort study BMC Surgery Pancreatic cancer Venous reconstruction technique Falciform ligament Patency Survival |
author_facet |
Yi Shao Jiaojiao Feng Yuancong Jiang Zhenhua Hu Jian Wu Min Zhang Yan Shen Shusen Zheng |
author_sort |
Yi Shao |
title |
Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort study |
title_short |
Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort study |
title_full |
Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort study |
title_fullStr |
Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort study |
title_full_unstemmed |
Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort study |
title_sort |
feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort study |
publisher |
BMC |
series |
BMC Surgery |
issn |
1471-2482 |
publishDate |
2021-01-01 |
description |
Abstract Background Mesentericoportal vein (MPV) resection in pancreatic ductal adenocarcinoma (PDAC) surgery has become a common procedure. A few studies had described the use of falciform ligament (FL) for MPV reconstruction and received encouraging preliminary effects. Aims This study was designed to explore the feasibility and efficacy of this technique compared with others. Methods Patients who underwent pancreaticoduodenectomy (PD) with MPV resection for PDAC from 2009 to 2018 were enrolled. Medical records were retrospectively reviewed, MPV reconstructions using FL were distinguished and compared with other techniques. Results 146 patients underwent MPV reconstruction, and 13 received FL venoplasty. Other reconstruction techniques included primary end-to-end anastomosis (primary, n = 30), lateral venorrhaphy (LV, n = 19), polytetrafluoroethylene conduit interposition (PTFE, n = 24), iliac artery (IA) allografts interposition (n = 47), and portal vein (PV) allografts interposition (n = 13). FL group holds the advantages of shortest operation time (p = 0.023), lowest blood loss (p = 0.109), and shortest postoperative hospital stay (p = 0.125). The grouped patency rates of FL, primary, LV, PTFE, IA, and PV were 100%, 90%, 68%, 54%, 68%, and 85% respectively. Comparison displayed that FL had the highest patency rate (p = 0.008) and lowest antiplatelet/anticoagulation proportion (p = 0.000). Complications and long-term survival were similar among different techniques. The median survival time of patent group (24.0 months, 95% CI: 22.0–26.0) was much longer than that of the thrombosed (17.0 months, 95% CI: 13.7–20.3), though without significant difference (P = 0.148). Conclusions PD with MPV resection and reconstruction by FL is safe, feasible, and efficacious, it might provide a potential benefit for patients. |
topic |
Pancreatic cancer Venous reconstruction technique Falciform ligament Patency Survival |
url |
https://doi.org/10.1186/s12893-020-01019-9 |
work_keys_str_mv |
AT yishao feasibilityofmesentericoportalveinreconstructionbyautologousfalciformligamentduringpancreaticoduodenectomycohortstudy AT jiaojiaofeng feasibilityofmesentericoportalveinreconstructionbyautologousfalciformligamentduringpancreaticoduodenectomycohortstudy AT yuancongjiang feasibilityofmesentericoportalveinreconstructionbyautologousfalciformligamentduringpancreaticoduodenectomycohortstudy AT zhenhuahu feasibilityofmesentericoportalveinreconstructionbyautologousfalciformligamentduringpancreaticoduodenectomycohortstudy AT jianwu feasibilityofmesentericoportalveinreconstructionbyautologousfalciformligamentduringpancreaticoduodenectomycohortstudy AT minzhang feasibilityofmesentericoportalveinreconstructionbyautologousfalciformligamentduringpancreaticoduodenectomycohortstudy AT yanshen feasibilityofmesentericoportalveinreconstructionbyautologousfalciformligamentduringpancreaticoduodenectomycohortstudy AT shusenzheng feasibilityofmesentericoportalveinreconstructionbyautologousfalciformligamentduringpancreaticoduodenectomycohortstudy |
_version_ |
1724342646704439296 |